Annual advances of Chinese minority traditional medicine in 2020

来源 :传统医学研究(英文版) | 被引量 : 0次 | 上传用户:sephinroth
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Chinese minority traditional medicine is a traditional medicine formed during the long-term medical practice of various ethnic groups and is the crystallization of the wisdom of the people in all ethnic groups in China. The unique meaning carried by Chinese minority traditional medicine makes it an inseparable and important part of traditional Chinese medicine. The rich clinical experience and theoretical studies with different Chinese minority traditional medicine provide new ideas and new methods for Chinese medicine development. The pieces of literature published in 2020 on the traditional application analyzed the phytochemical composition, pharmacological effects, and mechanisms of the different ethnic groups including Tibetan, Mongolian, Zhuang, Dai, and Uyghur medicines, among others. This study found that some projects were stalled or delayed due to the coronavirus disease 2019 outbreak in 2020 compared with 2019, resulting in a decrease in the number of articles in certain fields. However, studied on Chinese minority traditional medicine have shown an overall upward trend this year with the Tibetan, Mongolian, and Dai medicines as the top three. In addition, the Chinese minority traditional medicine application under the coronavirus disease 2019 epidemic situation background was also summarized. Consequently, this study found that among the Chinese minority traditional medicine-related publications in 2020, publications using Chinese minority traditional medicine to treat coronavirus disease 2019 account for a certain percentage. Thus, this article systematically reviews and summarizes the related research of Chinese minority traditional medicine published in 2020 and provides references for future Chinese minority traditional medicine development.
其他文献
Panax genus belonging to a family of Araliaceae grow in Asia (9 species) and in North America (2 species). Especially Panax ginseng was listed in Chinese medica
Tumor burden remains a global health problem that threatens human life worldwide.Over the past few years,the evolution of immune checkpoint inhibitors has repre